Meridian Bioscience to Hold Third Quarter Fiscal 2021 Financial Results Conference Call on August 6, 2021

Rhea-AI Summary

Meridian Bioscience, Inc. (NASDAQ: VIVO) announced it will release its third quarter fiscal 2021 financial results on August 6, 2021. A conference call with CEO Jack Kenny and CFO Bryan Baldasare is scheduled at 10:00 a.m. ET to discuss the results. Participants can join the call by dialing the appropriate numbers based on their location. A replay of the call will be available for 14 days after the event. Meridian specializes in diagnostic testing solutions and life science raw materials, providing critical products across various sectors globally.

Positive

• Scheduled financial results may indicate ongoing operational performance and transparency.
• Engagement with investors through a conference call enhances stakeholder communication.

Negative

• None.

CINCINNATI, July 14, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter fiscal 2021 financial results Friday, August 6, 2021.

Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.

To participate in the live call by telephone from the U.S., dial (866) 443-5802, or from outside the U.S., dial (513) 360-6924, and enter the audience pass code 3074079.

A replay will be available for 14 days beginning at 1:00 p.m. Eastern Time on August 6, 2021 by dialing (855) 859-2056 or (404) 537-3406 and entering pass code 3074079.

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

FAQ

When will Meridian Bioscience report its third quarter fiscal 2021 results?

Meridian Bioscience will report its third quarter fiscal 2021 results on August 6, 2021.

Who will participate in the Meridian Bioscience earnings call?

CEO Jack Kenny and CFO Bryan Baldasare will participate in the earnings call.

What time is the Meridian Bioscience conference call on August 6, 2021?

The conference call will begin at 10:00 a.m. Eastern Time.

How can I access the replay of the Meridian Bioscience earnings call?

The replay will be available for 14 days starting at 1:00 p.m. ET on August 6, 2021, by dialing the provided numbers.